Other recorded roll call
HB3057
Three day rule suspended
Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.
Failed Senate May 27, 2025
Nay (1)
Republicans (1)
0% yea among members casting a yea or nay vote (0–1).
Other recorded roll call
Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.
Failed Senate May 27, 2025
0% yea among members casting a yea or nay vote (0–1).